Baxter (NYSE: BAX) reported Q2 EPS of $0.87, in-line with the analyst estimate of $0.87. Revenue for the quarter came in at $3.75 billion versus the consensus estimate of $3.88 billion.

GUIDANCE:

Baxter sees FY2022 EPS of $3.60-$3.70, versus the consensus of $4.13.

For earnings history and earnings-related data on Baxter (BAX) click here.